相似文献
1
Who Has Therapy-Related AML?
Mediterr J Hematol Infect Dis. 2017 Mar 1;9(1):e2017025. doi: 10.4084/MJHID.2017.025. eCollection 2017.
2
Therapy-related leukemia and myelodysplasia: susceptibility and incidence.
Haematologica. 2007 Oct;92(10):1389-98. doi: 10.3324/haematol.11034.
3
Influence of DNA damage and repair upon the risk of treatment related leukemia.
Leuk Lymphoma. 2008 Feb;49(2):204-17. doi: 10.1080/10428190701769657.
4
Secondary leukemias induced by topoisomerase-targeted drugs.
Biochim Biophys Acta. 1998 Oct 1;1400(1-3):233-55. doi: 10.1016/s0167-4781(98)00139-0.
5
XPO1 Inhibition using Selinexor Synergizes with Chemotherapy in Acute Myeloid Leukemia by Targeting DNA Repair and Restoring Topoisomerase IIα to the Nucleus.
Clin Cancer Res. 2016 Dec 15;22(24):6142-6152. doi: 10.1158/1078-0432.CCR-15-2885. Epub 2016 Jun 29.
6
Therapy-related acute myelogenous leukemia associated with 11q23 chromosomal abnormalities and topoisomerase II inhibitors: report of four additional cases and brief commentary.
Leuk Lymphoma. 1993 Sep;11(1-2):141-5. doi: 10.3109/10428199309054742.
7
Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rare events related to DNA-topoisomerase II inhibitors?
J Clin Oncol. 1998 May;16(5):1890-6. doi: 10.1200/JCO.1998.16.5.1890.
8
Chemotherapy-related - late occurring - Philadelphia chromosome in AML, ALL and CML. Similar events related to treatment with DNA topoisomerase II inhibitors?
Leukemia. 1997 Sep;11(9):1571-4. doi: 10.1038/sj.leu.2400769.
9
Relationship between topoisomerase II and radiosensitivity in mouse L5178Y lymphoma strains.
Mutat Res. 1989 Jan;217(1):53-63. doi: 10.1016/0921-8777(89)90036-0.
10
Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976-1993 and on 5098 unselected cases reported in the literature 1974-2001.
Leukemia. 2002 Dec;16(12):2366-78. doi: 10.1038/sj.leu.2402713.
引用本文的文献
1
What is radiation-induced acute myeloid leukaemia/can it be accurately identified?
Leukemia. 2025 Jun;39(6):1334-1336. doi: 10.1038/s41375-025-02561-2. Epub 2025 Mar 27.
2
Vacuolar ATPase Is a Possible Therapeutic Target in Acute Myeloid Leukemia: Focus on Patient Heterogeneity and Treatment Toxicity.
J Clin Med. 2023 Aug 25;12(17):5546. doi: 10.3390/jcm12175546.
3
Myelodysplastic syndromes.
Nat Rev Dis Primers. 2022 Nov 17;8(1):74. doi: 10.1038/s41572-022-00402-5.
4
De Novo and Therapy-Related Myelodysplastic Syndromes: Analogies and Differences.
Mediterr J Hematol Infect Dis. 2022 May 1;14(1):e2022030. doi: 10.4084/MJHID.2022.030. eCollection 2022.
5
Recent drug approvals for newly diagnosed acute myeloid leukemia: gifts or a Trojan horse?
Leukemia. 2020 Mar;34(3):671-681. doi: 10.1038/s41375-019-0704-5. Epub 2020 Jan 8.
6
A Case of Therapy-related Acute Myeloid Leukemia Following Treatment with 5-Fluorouracil.
Cureus. 2018 Dec 24;10(12):e3769. doi: 10.7759/cureus.3769.
7
Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma.
Leuk Res. 2018 Nov;74:130-136. doi: 10.1016/j.leukres.2018.07.016. Epub 2018 Jul 19.
本文引用的文献
1
Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults.
JAMA Intern Med. 2016 Jun 1;176(6):816-25. doi: 10.1001/jamainternmed.2016.1548.
2
Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008.
Blood. 2013 Apr 11;121(15):2996-3004. doi: 10.1182/blood-2012-08-448068. Epub 2013 Feb 14.
3
The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950-2001.
Radiat Res. 2013 Mar;179(3):361-82. doi: 10.1667/RR2892.1. Epub 2013 Feb 11.
4
RadRAT: a radiation risk assessment tool for lifetime cancer risk projection.
J Radiol Prot. 2012 Sep;32(3):205-22. doi: 10.1088/0952-4746/32/3/205. Epub 2012 Jul 19.
5
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.
Blood. 2009 Jul 30;114(5):937-51. doi: 10.1182/blood-2009-03-209262. Epub 2009 Apr 8.
6
Interactive RadioEpidemiological Program (IREP): a web-based tool for estimating probability of causation/assigned share of radiogenic cancers.
Health Phys. 2008 Jul;95(1):119-47. doi: 10.1097/01.HP.0000291191.49583.f7.
7
Causation and causal inference in epidemiology.
Am J Public Health. 2005;95 Suppl 1:S144-50. doi: 10.2105/AJPH.2004.059204.
8
Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute.
Eur J Cancer. 2005 May;41(7):998-1006. doi: 10.1016/j.ejca.2005.01.006. Epub 2005 Feb 24.
9
Hematotoxicity in workers exposed to low levels of benzene.
Science. 2004 Dec 3;306(5702):1774-6. doi: 10.1126/science.1102443.
10
Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy.
Blood. 2004 Dec 15;104(13):3872-7. doi: 10.1182/blood-2004-06-2161. Epub 2004 Aug 31.
Zotero 插件